Most patients regain weight after stopping GLP-1 medications, with clinical trials showing approximately two-thirds of lost weight returns within one year
Novel peptide-based approaches, such as those being tested in clinical trials for Stimuvax and Melanotan, have been made possible by the ongoing discovery of new therapeutic targets brought about by improvements in our knowledge of the molecular pathways underlying cancer 38
Its proven anti-inflammatory effect (particularly in respect to heart health), the role of the reninangiotensin system in heart health and the immune response in general, and the importance of inflammation in infection led Lonza to explore the impact of L-carnitine on COVID-19 outcomes
Discontinue if irritation occurs
If you would like further information about available services, speak to a member of the pharmacy team who can advise on appropriate next steps and available consultation options
Cancer Discovery (2018) 8(5):53755